COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study

hemato-oncology, COVID-19, Syndicated Studies, Oncology

How does COVID-19 affect the HCPS relationships with patients and with the pharmaceutical...

mRCC: promising new combinations lead to disruption in L1 and L2

Syndicated Studies, Oncology

Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...